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Suppressors of cytokine signalling (SOCS) proteins regulate signal transduction, but their role in
responses to chemokines remains poorly understood. We report that cells expressing SOCS1 and 3
exhibit enhanced adhesion and reduced migration towards the chemokine CCL11. Focal adhesion
kinase (FAK) and the GTPase RhoA, control cell adhesion and migration and we show the presence
of SOCS1 or 3 regulates expression and tyrosine phosphorylation of FAK, while also enhancing acti-
vation of RhoA. Our novel ﬁndings suggest that SOCS1 and 3 may control chemotaxis and adhesion
by signiﬁcantly enhancing both FAK and RhoA activity, thus localizing immune cells to the site of
allergic inﬂammation.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Extravasation of leukocytes from the blood vessels into tissue is
fundamental for the development of an effective allergic inﬂamma-
tory response. Chemokines are a family of secreted proteins that
regulate migration of leukocytes and mediate their biological effect
through G-protein-coupled receptors on the surface of their target
cells. Chemokines are also responsible for abnormal, excessive leu-
kocyte recruitment during allergic inﬂammatory disease, such as
asthma and contact dermatitis, which has increased attempts to
therapeutically manipulate their effects [1].
CCL11 is a chemokine originally identiﬁed as an eosinophil che-
moattractant, but now known to be chemotactic for many cellschemical Societies. Published by E
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).that express its receptor, CCR3, including macrophages and neutro-
phils [2,3]. CCL11 signals via activation of signalling proteins,
including mitogen-activated protein kinases, extracellular signal-
regulated kinases and protein kinase C [4] and we have shown that
CCL11 uses suppressors of cytokine signalling (SOCS) induction to
block granulocyte macrophage-colony stimulating factor (GM-CSF)
and interleukin (IL)-4 signalling and thus regulate dendritic cell
differentiation [5]. However, the speciﬁc regulation of CCL11 intra-
cellular signalling or migration has not been investigated.
SOCS are a family of 8 proteins (cytokine-inducible SH2-contain-
ing protein and SOCS1-7) that act in a negative feedback loop, inhib-
iting responses to cytokines and a number of microbial products,
including Interferon (IFN)-c, IL-6 and lipopolysaccharide [6]. SOCS
were ﬁrst discovered as inhibitors of the Janus kinase/signal trans-
ducer and activator of transcription (JAK/STAT) pathway [7,8]; how-
ever theyare increasingly thought to control otherpathways, suchas
the focal adhesion kinase (FAK) signalling pathway [9–11]. FAK is a
tyrosine kinase, crucial in signalling from integrins and receptor
tyrosine kinases during migration and adhesion. FAK is recruited
to sites of integrin clustering,which induces tyrosine-397phosphor-
ylation and creates a binding site for Src kinases leading to Rho
GTPase activation. Rho GTPases are plasma-membrane bound
G-proteins that control the formation and disassembly of the actinlsevier B.V. All rights reserved.
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inactive (GDP-bound) and active (GTP-bound) state and their activ-
ity is positively regulated by guanine nucleotide exchange factors
(GEFs) and negatively regulated by GTPase-activating proteins.
FAKenhancesRhoAactivity via associationswithGEFs and thus con-
trols actin and microtubule polarization [12]. While SOCS1 and 3
havebeenshowntoassociatewithFAKand inhibit its kinaseactivity,
their effects on Rho GTPases are not known.
This study demonstrates that SOCS1 and 3 strongly enhance cell
adhesion and inhibit migration towards CCL11. The presence of
these SOCS enhanced both FAK expression and phosphorylation,
while also increasing activity of RhoA, which may be responsible
for the rise in adhesion and inhibition of chemotaxis. Our observa-
tions directly implicate SOCS1 and 3 in the regulation of FAK and
RhoA-mediated cell mobility, which is crucial in understanding
inﬂammatory-mediated migration.
2. Materials and methods
2.1. Cell culture
Murine embryonic ﬁbroblasts (MEFs) and human embryonic
kidney (HEK) 293T cells were grown in Dulbecco’s Modiﬁed Eagle
Media (DMEM) supplemented with 10% fetal calf serum, 1% L-glu-
tamine and 1% pen/strep. Cells were cultured at 37 C in 5% CO2
and 95% humidity. SOCS-1/ MEFs were retro-virally infected
with SOCS1 pMX-IRES-EGFP and SOCS3/ MEFs with SOCS3
pMX-IRES-EGFP as described previously [13]. Cells were treated
with 100 ng/ml human CCL11 (Peprotech, Rocky Hill, NJ). Bone
marrow-derived macrophages (BMDMs) were prepared from
C57/BL6 wild-type (WT) and LysM+/cre SOCS3 ﬂ/ﬂ mice and cul-
tured for 1 week in DMEM, supplemented as above. Proliferation
was driven by GM-CSF derived from L929 cell supernatant.
2.2. Migration assay
Cell migration towards CCL11 was assessed using Boyden
chambers with transwell membranes over 12 h (6.0-mm diameter,
8-um pore size [Receptor Technologies]) as previously described
[14]. 293T migration was measured as cell count from confocal
images. MEF and BMDM migration was measured by ﬁxing the
cells for 10 min in methanol and staining with crystal violet solu-
tion (0.05% crystal violet and 25% methanol) for 20 min. Mem-
branes were destained for 20 min with destaining solution (1:1,
ethanol:0.2 M sodium citrate) and optical density was measured
at A570.
2.3. Immunoblot analysis
Protein expression was assessed from cells lysed in Brij lysis
buffer (0.05 M Tris–HCl pH7.4, 0.15 M NaCl, 1  103 M EDTA pH
8, 1% Brij 97) supplemented with aprotinin (5 lg/ml), leupeptin
(5 lg/ml), phenylmethylsulfonyl ﬂuoride (1 mM) and Na3VO4
(1 mM). Extracts were pelleted at 12 000g, 4 C for 10 min. Ly-
sates were analysed by poly-acrylamide gel electrophoresis. SOCS1
(Invitrogen), SOCS3 (Santa Cruz Biotechnologies, CA), pY397FAK
and FAK (Biosource), b1 integrin (Cell signal), and c-tubulin
(Sigma) were detected using the appropriate antibodies.
2.4. Confocal imaging
Cells were seeded and transfected on LabTek II, CC2 treated
chamber slides. Cells were ﬁxed using 4% paraformaldehyde in
1XPBS for 20 min. The cells were then permeabilised in 0.5% Triton
X-100 in 1XPBS for 5 min, washed in 1XPBS and blocked in block-ing solution (1% BSA, 10% Donkey Serum in 1XPBS) for 1 h at room
temperature (RT). Cells were stained with pY397FAK or pY925FAK
(Cell Signal) and Alexaﬂuor 488 anti-rabbit secondary antibody
(Molecular Probes), Talin (Sigma) and Alexaﬂuor 568 anti-mouse
secondary antibody (Molecular Probes) and also Phalloidin-FITC
(Sigma) for F-actin. The slides were sealed with a cover slip and
anti-fade mountant (Invitrogen) and analysed using a confocal
microscope and LAS AF software (Leica).
2.5. Adhesion assay
96-well plates were coated with ﬁbrinogen (20 g/ml) for 1 h at
RT before 100 lL of cells (1  105/ml) were added for 0–60 min.
Adhered cells were stained with crystal violet solution (as above)
for 20 min, before being washed with 1XPBS and destained for
20 min in destaining solution (as above) and the optical density
was measured at A570.
2.6. GTPase activation assays
RhoA activation was measured by GTP pull down assay as de-
scribed previously [15]. Cells were washed with 1XPBS and lysed
in lysis buffer (50 mM Tris pH 7.2, 500 mM NaCl, 1% (v/v) Triton
X-100, 5 mM MgCl2, 1 mM DTT) containing protease inhibitors
(as above). Lysates were incubated at 4 C for 1 h with GST–Rhot-
ekin fusion protein coupled to glutathione-sepharose beads (Amer-
sham Biosciences). After incubation, beads were centrifuged at
8 000g and washed in lysis buffer. Beads were boiled in Laemmli
buffer. Active GTPases were detected by immunoblotting with
anti-RhoA antibody (Santa Cruz) and lysate was analysed to quan-
tify total Rho.
2.7. Statistical analysis
Migration and adhesion data were represented as bar graphs,
created from the raw data in microsoft excel. Groups were then
compared using Student’s t-test for statistical signiﬁcance
(*P 6 0.05, **P 6 0.01 and ***P 6 0.001).
3. Results
3.1. SOCS1 and 3 expression inhibit chemotaxis towards CCL11
SOCS1 and 3 have been linked to a block in ﬁbronectin-medi-
ated mobility [10,11], but their function in chemokine-induced
migration remains unexplored. Therefore, we analysed the effect
of SOCS1, 2 and 3 on chemotaxis towards CCL11. CCR3 and SOCS1,
2 or 3 were transfected into HEK293T cells, before migration to-
wards CCL11 was measured using a Boyden chamber. CCR3 levels
were conﬁrmed by ﬂow cytometry and SOCS expression by immu-
noblotting (data not shown). SOCS2 had no effect on CCL11-in-
duced migration, but both SOCS1 and 3 signiﬁcantly reduced cell
mobility (Fig. 1A). Having identiﬁed SOCS1 and 3 as potent inhib-
itors of migration, we veriﬁed their speciﬁc involvement by analys-
ing CCL11-induced migration in WT, SOCS1 and 3 null and
expressing MEFs. We found that WT, SOCS1 and 3 null cells mi-
grated towards CCL11 signiﬁcantly more than SOCS expressing
cells (Fig. 1B, C and D). Interestingly, SOCS3 null cells migrated
more than SOCS1 nulls. SOCS expression was conﬁrmed by wes-
tern blotting (Fig. 1E). Migration of WT and SOCS3 null BMDMs to-
wards CCL11 was also investigated. BMDMs lacking SOCS3 showed
signiﬁcantly enhanced migration towards CCL11, compared to cells
fromWT mice (Fig. 1F). These ﬁndings support the hypothesis that
both SOCS1 and 3 control chemotactic responses to CCL11 and
therefore regulate cell movement during allergic inﬂammation.
Fig. 1. SOCS1 and 3 regulate migration towards CCL11. HEK293T cells were transfected with 5 lg of CCR3 and SOCS1-3 constructs, before chemotaxis using 100 ng/ml CCL11
(A). Chemotaxis was also analysed using SOCS1 and 3 null and stable and WT MEFs towards CCL11 (5 ng/ml) (B–D). Data are mean ± S.E.M. (n = 3). SOCS1 and 3 expression
was conﬁrmed by immunoblotting (E) (n = 3). Migration of WT and SOCS3 null BMDMs towards CCL11 (5 ng/ml) was measured (F).
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Having discovered that SOCS inhibited CCL11-induced migra-
tion of epithelial cells, ﬁbroblasts and macrophages, we investi-
gated the effect of SOCS1 and 3 on cell adhesion. We analysedadhesion to ﬁbrinogen of WT, SOCS null and SOCS expressing MEFs,
at 0, 5, 15, 30 and 60 min. We found WT MEFs had maximal adher-
ence at 20 min. SOCS3 expressing cells adhered signiﬁcantly more
than cells lacking SOCS3, with maximal adherence being observed
between 30 and 60 min. SOCS1 expressing cells also adhered sig-
Fig. 2. SOCS1 and 3 enhance cell adhesion. WT, SOCS1 and 3 null and stable MEFs
were incubated for 0–60 min on ﬁbrinogen coated 96-well plates. Cells were
stained with crystal violet and the optical density of the detaining solution was
correlated to cell adhesion (A). Adherence of SOCS3 null BMDMs was also measured
for 0 and 60 min (B). Data are means ± S.E.M. (n = 3).
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between 20 and 30 min (Fig. 2A). We also found that WT BMDMs
adhered signiﬁcantly more to ﬁbrinogen than cells without SOCS3,
reafﬁrming SOCS3’s positive regulatory role in adherence (Fig. 2B).
Together our results indicate that both SOCS1 and 3 reduce CCL11-
mediated migration, but enhance adhesion, unveiling a novel
mechanism of chemotactic regulation.3.3. SOCS1 and 3 enhance FAK expression and tyrosine
phosphorylation
Since we found SOCS1 and 3 to inhibit CCL11-mediated migra-
tion and enhance adherence, we were interested to explore which
intracellular proteins were affected. Since FAK activation promotes
cell attachment and migration [16], we analysed its expression and
phosphorylation, in response to CCL11, in SOCS1 and 3 null and
expressing cells. We found that SOCS1 and 3 null cells expressed
low endogenous FAK levels and lacked tyrosine-397 phosphoryla-
tion (Fig. 3A and B). However, protein and tyrosine phosphoryla-
tion were upregulated by CCL11 stimulation (Fig. 3A and B). In
contrast, constitutive FAK expression and phosphorylation were
enhanced in both SOCS1 and 3 expressing MEFs (Fig. 3A and B).
WT MEFs expressed low levels of FAK and low endogenous FAK
phosphorylation was enhanced upon CCL11 treatment (Fig. 3C).
To further investigate FAK phosphorylation, we analysed pFAK by
confocal microscopy in WT, stable and null SOCS1 and 3 MEFs.
Conﬁrming the results obtained by immunoblotting, pY397FAK
(Fig. 3D) and pY925FAK (Supplementary Fig. 1) had high constitu-
tive expression in SOCS expressing cells, compared to low levels in
WT or SOCS null equivalent cells. pFAK also localized at protruding
cell surfaces with the adhesion marker protein, talin and the cyto-
skeletal protein, F-actin, in SOCS1 and 3 expressing cells, indicating
enhanced FAK activation in focal adhesion sites (Fig. 3D and
Supplementary Fig. 1). As with FAK, basal levels of b1 integrin were
lower in WT, SOCS1 and 3 null cells compared to SOCS expressing
cells. b1 integrin expression showed a similar pattern of induction
to pFAK and was upregulated in SOCS1 null cells by CCL11, but re-
mained low in SOCS3 null cells (Fig. 3E). These results indicate that
SOCS1 and 3 enhance endogenous FAK expression and activation at
sites of cell adhesion, providing a molecular mechanism for in-
creased adhesion and thus reduced migration.
3.4. SOCS1 and 3 enhance RhoA GTPase activation
GTP-bound RhoA is responsible for actin remodelling and thus
essential for adhesion and migration [17]. Therefore, having ob-
served that both SOCS1 and 3 enhanced pFAK expression, we ana-
lysed the activation of RhoA by CCL11 in both SOCS1 and 3 null and
stable MEFs. We discovered that GTP-bound RhoA is basally high in
SOCS1 and 3 expressing cells and CCL11 induced further activation
in SOCS3 stable cells. However, basal levels of RhoA were attenu-
ated in the absence of either SOCS (Fig. 3F). These results suggest
that SOCS1 and 3 expression leads to RhoA activation, which
may increase cell adhesion. Taken together our results suggest that
SOCS1 and 3 stabilise FAK protein expression and enhance its tyro-
sine phosphorylation, while also increasing RhoA activation, which
may increase cell adhesion and reduce migration.
4. Discussion
This study reveals a novel role for SOCS1 and 3 in the regulation
of FAK and RhoA-mediated cell movement. We have shown that
SOCS1 and 3 expression blocks migration towards CCL11, possibly
through increased cell adhesion. The observed effects on cell
mobility may be regulated by increased levels of activated FAK
and RhoA.
Our interest in SOCS-controlled migration was prompted by
massive inﬁltration of T lymphocytes, macrophages and eosino-
phils into major organs, such as the liver, heart and pancreas ob-
served in SOCS1/ mice [7,18,19] and granulomatous lesions
and chronic inﬁltrates of lymphocytes, macrophages, eosinophils
and neutrophils into the lungs, skin, gut and abdominal organs in
SOCS1/IFN-c/ mice [20]. This phenotype was thought to be
Fig. 3. SOCS1 and 3 regulate FAK activation and expression, b1 integrin expression and RhoA GTPase activation. SOCS1 (A) and 3 (B) null, stable and WT (C) MEFS were
stimulated with CCL11 (100 ng/ml) for 0–60 min before lysates were analysed for pFAK, FAK and c-tubulin by immunoblotting. pFAK (green), talin (red) and F-actin (red)
were analysed in WT, SOCS1 and 3 null and stable cells by confocal microscopy (D). b1 Integrin levels were analysed by Western blotting lysates from WT, SOCS1 and 3 null
and stable MEFs stimulated for 0, 30 and 60 min with CCL11 (100 ng/ml) (E). SOCS1 and 3 stable and null MEFs were treated with CCL11 (100 ng/ml) for 0, 5 and 15 min and
the activation of RhoA assessed by pull down assay using GST-Rhotekin. Proteins extracted by pull down and whole cell lysates were immunoblotted with anti-RhoA antibody
(F).
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control adhesion and migration towards chemoattractants, such
as CCL11, and that this may be a fundamental aspect of inﬂamma-
tory control.
Previous studies have shown SOCS1 and 3 to interact with FAK,
promote its degradation and thus reduce migration to ﬁbronectin
[10,11,21]. In contrast, we discovered enhanced expression and
tyrosine phosphorylation of FAK in the presence of SOCS1 or 3.
We went on to ﬁnd that these cells, with enhanced pFAKexpression, had increased cell adhesion which may explain the
reduction in chemokine-induced migration. While a common ﬁnd-
ing is SOCS-mediated reduction in migration, the discrepancy in
FAK expression and activation may be cell type or species speciﬁc,
since previous studies used human hepatoma and monkey kidney
cell lines and our investigations were carried out with human kid-
ney cells, murine ﬁbroblasts and macrophages.
The exact role of FAK in cell migration is debated. FAK/ ﬁbro-
blasts show reduced motility [22–24], but siRNA knockdown in
4474 N.J. Stevenson et al. / FEBS Letters 584 (2010) 4469–4474HeLa enhances migration on collagen [25] and over-expression of
FAK in Chinese hamster ovary cells also enhances cell migration
[26]. Therefore, it seems that FAK activity may vary between cells
and migratory stimulus. Transient FAK activation is required for IL-
8-mediated migration, however, desensitizing levels of IL-8 cause
constitutive FAK phosphorylation [27], similar to our ﬁndings in
SOCS1 and 3 expressing MEFs. We previously demonstrated that
IL-8 induces both SOCS1 and 3 expression [28], which explains
desensitization to IL-8. Constant FAK phosphorylation renders leu-
kocytes unable to cycle between attachment and detachment,
essential for cell movement. Therefore, consistent FAK activation,
such as that observed with excess IL-8 or in SOCS1 or 3 expressing
MEFs may promote excessive adhesion, resulting in reduced
migration.
This study demonstrates for the ﬁrst time that SOCS1 and 3 en-
hance FAK and RhoA activation, leading to increased cell adhesion
and reduced migration towards CCL11. Our novel ﬁndings are
important in the context of both normal cell migration and allergic
inﬂammation and unveil new therapeutic targets for controlling
excessive or inappropriate inﬂammatory responses.
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